Provided by Tiger Trade Technology Pte. Ltd.

NeuroPace Inc.

14.81
+0.13000.89%
Post-market: 14.810.00000.00%19:34 EDT
Volume:268.93K
Turnover:3.95M
Market Cap:504.93M
PE:-22.82
High:15.00
Open:14.87
Low:14.28
Close:14.68
52wk High:19.60
52wk Low:7.56
Shares:34.09M
Float Shares:23.28M
Volume Ratio:1.38
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6489
EPS(LYR):-0.6560
ROE:-111.38%
ROA:-10.02%
PB:34.93
PE(LYR):-22.58

Loading ...

Neuropace Inc : Mizuho Initiates Coverage with Outperform Rating; Target Price $22

THOMSON REUTERS
·
Jul 23

NeuroPace Shareholders Approve Directors and Auditor at Meeting

TIPRANKS
·
Jun 09

NeuroPace shareholders elect directors at annual meeting

Reuters
·
Jun 09

NeuroPace attends ASSFN meeting, spotlights expanding role of responsive neuromodulation in epilepsy care

Reuters
·
May 29

NeuroPace wins FDA approval for ECoG Assistant AI epilepsy feature

Reuters
·
May 29

Neuropace Announces FDA Approval of Ecog Assistant™, Advancing AI-Driven Epilepsy Care

THOMSON REUTERS
·
May 29

Analysts Conflicted on These Healthcare Names: NeoGenomics (NEO) and NeuroPace (NPCE)

TIPRANKS
·
May 27

NeuroPace price target raised to $20 from $19 at H.C. Wainwright

TIPRANKS
·
May 16

NeuroPace Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 16

NeuroPace Earnings Call Highlights RNS Growth Momentum

TIPRANKS
·
May 14

NeuroPace (NPCE) Receives a Buy from Lake Street

TIPRANKS
·
May 13

NeuroPace: Buy Rating Reiterated on Raised Guidance, Differentiated RNS Platform, and Attractive $20 Price Target Versus High-Growth Med-Tech Peers

TIPRANKS
·
May 13

Neuropace Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

NeuroPace Q1 Loss Narrows, Revenue Declines

MT Newswires Live
·
May 13

NeuroPace Q1 revenue rises 20%, beats estimates, raises 2026 outlook

Reuters
·
May 13

NeuroPace Q1 EPS $(0.20) Beats $(0.23) Estimate, Sales $22.068M Beat $21.644M Estimate

Benzinga
·
May 13

NeuroPace Q1 net loss widens to $6.7 million; revenue rises 20.1% to $22 million

Reuters
·
May 13

BRIEF-NeuroPace, Inc. Q1 EPS USD -0.2

Reuters
·
May 13

Neuropace, Inc. Q1 EPS USD -0.2

THOMSON REUTERS
·
May 13

Press Release: NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance

Dow Jones
·
May 13